Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer
Authors
Keywords
-
Journal
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 325, Issue 13, Pages 1277
Publisher
American Medical Association (AMA)
Online
2021-04-06
DOI
10.1001/jama.2021.2454
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Evaluation of the Change of Outcomes over a Ten-Year Period in Patients with Stage III Colon Cancer: Pooled Analysis of 6501 Patients Treated with Fluorouracil, Leucovorin, and Oxaliplatin in the ACCENT Database
- (2020) M.E. Salem et al. ANNALS OF ONCOLOGY
- Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
- (2019) Nalinie Joharatnam-Hogan et al. Lancet Gastroenterology & Hepatology
- Aspirin versus placebo in stage III or high-risk stage II colon cancer with PIK3CA mutation: A French randomised double-blind phase III trial (PRODIGE 50-ASPIK)
- (2018) Pierre Michel et al. DIGESTIVE AND LIVER DISEASE
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- (2018) Axel Grothey et al. NEW ENGLAND JOURNAL OF MEDICINE
- The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients
- (2018) Marilena Petrera et al. BMC CANCER
- Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis
- (2014) Peiwei Li et al. GUT
- Expression of HLA Class I Antigen, Aspirin Use, and Survival After a Diagnosis of Colon Cancer
- (2014) Marlies S. Reimers et al. JAMA Internal Medicine
- Aspirin Use and Risk of Colorectal Cancer According to BRAF Mutation Status
- (2013) Reiko Nishihara et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluation of PIK3CA Mutation As a Predictor of Benefit From Nonsteroidal Anti-Inflammatory Drug Therapy in Colorectal Cancer
- (2013) Enric Domingo et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
- (2012) Annemijn M Algra et al. LANCET ONCOLOGY
- Aspirin Use, TumorPIK3CAMutation, and Colorectal-Cancer Survival
- (2012) Xiaoyun Liao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview
- (2011) A. T. Chan et al. Cancer Prevention Research
- Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer
- (2011) Daniel G. Haller et al. JOURNAL OF CLINICAL ONCOLOGY
- The utility of Aspirin in dukes C and high risk dukes B colorectal cancer - The ASCOLT study: study protocol for a randomized controlled trial
- (2011) Raghib Ali et al. Trials
- Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer
- (2010) A. E. Coghill et al. GUT
- Effect of aspirin and NSAIDs on risk and survival from colorectal cancer
- (2010) Farhat V N Din et al. GUT
- Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR Trial
- (2010) Rachel S. Midgley et al. JOURNAL OF CLINICAL ONCOLOGY
- Aspirin Use and Survival After Diagnosis of Colorectal Cancer
- (2009) Andrew T. Chan JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A review of gene-drug interactions for nonsteroidal anti-inflammatory drug use in preventing colorectal neoplasia
- (2008) J T Cross et al. PHARMACOGENOMICS JOURNAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started